Additionally, the TCGA database showed that RPLP0 and NONO were highly expressed in a variety of cancer types (Fig. S6A), and survival analysis confirmed that high expression of RPLP0 and NONO was associated with an inferior prognosis of cancer patients (Fig. S6B, C). The gene discussed is RPLP0; the disease is cancer.